- Home
- IPHA vs SPCE Comparison
IPHA vs SPCE Comparison
Compare IPHA & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- SPCE
- Stock Information
- Founded
- IPHA 1999
- SPCE 2017
- Country
- IPHA France
- SPCE United States
- Employees
- IPHA 179
- SPCE N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- SPCE Transportation Services
- Sector
- IPHA Health Care
- SPCE Consumer Discretionary
- Exchange
- IPHA Nasdaq
- SPCE Nasdaq
- Market Cap
- IPHA 191.0M
- SPCE 166.3M
- IPO Year
- IPHA 2019
- SPCE N/A
- Fundamental
- Price
- IPHA $2.29
- SPCE $6.37
- Analyst Decision
- IPHA Strong Buy
- SPCE Hold
- Analyst Count
- IPHA 1
- SPCE 6
- Target Price
- IPHA $11.50
- SPCE $31.50
- AVG Volume (30 Days)
- IPHA 5.8K
- SPCE 1.1M
- Earning Date
- IPHA 09-12-2024
- SPCE 11-06-2024
- Dividend Yield
- IPHA N/A
- SPCE N/A
- EPS Growth
- IPHA N/A
- SPCE N/A
- EPS
- IPHA N/A
- SPCE N/A
- Revenue
- IPHA $68,134,188.00
- SPCE $10,742,000.00
- Revenue This Year
- IPHA N/A
- SPCE N/A
- Revenue Next Year
- IPHA $105.84
- SPCE N/A
- P/E Ratio
- IPHA N/A
- SPCE N/A
- Revenue Growth
- IPHA 6.88
- SPCE 175.51
- 52 Week Low
- IPHA $1.81
- SPCE $5.27
- 52 Week High
- IPHA $3.15
- SPCE $54.60
- Technical
- Relative Strength Index (RSI)
- IPHA 55.19
- SPCE 45.36
- Support Level
- IPHA $2.22
- SPCE $5.75
- Resistance Level
- IPHA $2.41
- SPCE $6.84
- Average True Range (ATR)
- IPHA 0.12
- SPCE 0.37
- MACD
- IPHA 0.01
- SPCE 0.02
- Stochastic Oscillator
- IPHA 76.47
- SPCE 29.94
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures advanced air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.